Stiefel, a GlaxoSmithKline company, has expanded its Revaleskin portfolio with the new Revaleskin HydraLift Complex.
GlaxoSmithKline company Stiefel announced it is seeking approval for a facial acne treatment in patients ages 12 years and older.
Stiefel, a GlaxoSmithKline company, has expanded its Revaleskin family of products with its new Revaleskin Illuminesse Brightening Complex.
The Food and Drug Administration has approved a new indication for an epilepsy drug made by GlaxoSmithKline, the drug maker said Monday.
GlaxoSmithKline said it is establishing a dedicated team to support community pharmacists and other healthcare professionals.
GlaxoSmithKline company Stiefel has made its popular acne wash formulations available for over-the-counter use.
Watson Pharmaceuticals biotech subsidiary Eden Biodesign has signed a manufacturing agreement with Dutch biotech company...
GlaxoSmithKline is offering its vaccines free of charge to low-income adults, the British drug maker...